Peter R. Mullins

820 total citations
20 papers, 620 citations indexed

About

Peter R. Mullins is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Peter R. Mullins has authored 20 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Peter R. Mullins's work include Diabetes Management and Research (6 papers), Diabetes Treatment and Management (5 papers) and Pneumonia and Respiratory Infections (3 papers). Peter R. Mullins is often cited by papers focused on Diabetes Management and Research (6 papers), Diabetes Treatment and Management (5 papers) and Pneumonia and Respiratory Infections (3 papers). Peter R. Mullins collaborates with scholars based in New Zealand, United States and Germany. Peter R. Mullins's co-authors include Ronald G. Kay, I. M. Holdaway, Matthew C. Riddle, Barbara Mason, Hans‐Ulrich Häring, Hannele Yki‐Järvinen, P Sharplin, Graham Mills, Francesco Blasi and L. Allegra and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Cancer and Pain.

In The Last Decade

Peter R. Mullins

19 papers receiving 584 citations

Peers

Peter R. Mullins
Julio Santiago United States
Hannah C. Ainsworth United States
Denise Ramjit United States
A. Wolf Germany
Monia Elasmi Tunisia
Julio Santiago United States
Peter R. Mullins
Citations per year, relative to Peter R. Mullins Peter R. Mullins (= 1×) peers Julio Santiago

Countries citing papers authored by Peter R. Mullins

Since Specialization
Citations

This map shows the geographic impact of Peter R. Mullins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Mullins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Mullins more than expected).

Fields of papers citing papers by Peter R. Mullins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Mullins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Mullins. The network helps show where Peter R. Mullins may publish in the future.

Co-authorship network of co-authors of Peter R. Mullins

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Mullins. A scholar is included among the top collaborators of Peter R. Mullins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Mullins. Peter R. Mullins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Owens, David R., Louise Traylor, Peter R. Mullins, & Wolfgang Landgraf. (2016). Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy. Diabetes Research and Clinical Practice. 124. 57–65. 23 indexed citations
2.
Lankisch, Mark, Stefano Del Prato, Marie‐Paule Dain, Peter R. Mullins, & David R. Owens. (2015). Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials. Primary care diabetes. 10(1). 51–59. 13 indexed citations
6.
Broadley, Simon, Daina Vanags, Brett Williams, et al.. (2009). Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis.. PubMed. 15(3). 329–36. 1 indexed citations
7.
Swinnen, S. G. H. A., et al.. (2008). Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia. 52(1). 38–41. 44 indexed citations
8.
Vanags, Daina, Bryan Williams, Barbara J. Johnson, et al.. (2008). Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis. Multiple Sclerosis Journal. 15(3). 329–336. 30 indexed citations
9.
Mullins, Peter R., P Sharplin, Hannele Yki‐Järvinen, Matthew C. Riddle, & Hans‐Ulrich Häring. (2007). Negative Binomial Meta-Regression Analysis of Combined Glycosylated Hemoglobin and Hypoglycemia Outcomes Across Eleven Phase III and IV Studies of Insulin Glargine Compared with Neutral Protamine Hagedorn Insulin in Type 1 and Type 2 Diabetes Mellitus. Clinical Therapeutics. 29(8). 1607–1619. 115 indexed citations
10.
Blasi, Francesco, Christine Jenkins, R Scicchitano, et al.. (2001). Trial of Roxithromycin in Subjects with Asthma and Serological Evidence of Infection with Chlamydia pneumoniae. American Journal of Respiratory and Critical Care Medicine. 164(4). 536–541. 116 indexed citations
11.
Mullins, Peter R., et al.. (1994). Clinical Efficacy of Roxithromycin in the Treatment of Adults with Upper and Lower Respiratory Tract Infection Due to Haemophilus influenzae. Clinical Drug Investigation. 7(6). 299–314. 8 indexed citations
12.
Houston, I. B., I. Lyon, B. A. MacArthur, et al.. (1988). Transient neonatal tyrosinaemia. Journal of Inherited Metabolic Disease. 12(1). 13–22. 18 indexed citations
13.
Mason, B., I. M. Holdaway, Peter R. Mullins, Ronald G. Kay, & S.J.M. Skinner. (1985). Seasonal variation in breast cancer detection: Correlation with tumour progesterone receptor status. Breast Cancer Research and Treatment. 5(2). 171–176. 29 indexed citations
14.
McInerney, Paul‐Brian, et al.. (1984). STATCALC: An integrated statistics system for the Apple II microcomputer. Computer Programs in Biomedicine. 18(3). 265–272. 11 indexed citations
15.
Kay, Ronald G., et al.. (1983). Levamisole in primary breast cancer. A controlled study in conjunction with L-phenylalanine mustard. Cancer. 51(11). 1992–1997. 7 indexed citations
16.
Mason, Barbara, et al.. (1983). Progesterone and estrogen receptors as prognostic variables in breast cancer.. PubMed. 43(6). 2985–90. 123 indexed citations
17.
Koelmeyer, Timothy D., et al.. (1982). A computer-based analysis of injuries sustained by victims of a major air disaster. American Journal of Forensic Medicine & Pathology. 3(1). 11–16. 5 indexed citations
18.
Lang, S. D. R., et al.. (1981). Anomalous Effect of Serum on the Antimicrobial Activity of Cefoperazone. Drugs. 22(Supplement 1). 52–59. 13 indexed citations
19.
Large, Robert G. & Peter R. Mullins. (1981). Illness behaviour profiles in chronic pain: The auckland experience. Pain. 10(2). 231–239. 7 indexed citations
20.
Lorimer, Peter & Peter R. Mullins. (1977). Ramsey numbers for quadrangles and triangles. Journal of Combinatorial Theory Series B. 23(2-3). 262–265. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026